Access Statistics for Fabio Pammolli

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Breath of Fresh Air? Firm Type, Scale, Scope and Selection Effects in Drug Development 0 0 0 0 1 4 5 183
A Breath of Fresh Air? Firm types, scale, scope and selection effects in drug development 0 0 1 49 0 3 14 188
A Comparison of U.S. And European University-Industry Relations in the Life Sciences 0 0 0 0 0 0 2 353
A Comparison of U.S. and European University-Industry Relations in the Life Sciences 0 0 2 61 0 3 9 291
A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence 0 0 0 3 0 0 0 32
A Generalized Preferential Attachment Model for Business Firms Growth Rates: I. Empirical Evidence 0 0 0 8 0 0 1 61
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment 0 0 0 5 0 0 1 73
A Generalized Preferential Attachment Model for Business Firms Growth Rates: II. Mathematical Treatment 0 0 0 3 0 1 1 57
Access to Medicines and European Market Integration 0 0 3 24 0 1 8 48
Alcuni vantaggi "minori" del contributivo: Ricongiunzione e Totalizzazione 0 0 0 5 0 1 2 54
Assessing financial distress dependencies in OTC markets: a new approach by Trade Repositories data 0 1 1 20 0 4 5 29
Auctions vs. Bargaining: An Empirical Analysis of Medical Device Procurement 0 0 1 144 0 4 5 465
Betweenness Centrality of Fractal and Non-Fractal Scale-Free Model Networks and Tests on Real Networks 0 0 1 21 0 0 4 132
Co-evolution of Organizational Forms and Technology 0 0 0 0 0 0 0 244
Competencies, Technological Change and Network Dynamics. The case of the bio-pharmaceutical industry 0 0 0 233 0 0 0 445
Crescita, occupazione e sostenibilità - Il ruolo delle infrastrutture digitali 0 0 1 11 1 1 3 66
Demography, Sustainability, and Growth Notes on the future of the European "Social Market" Economy 0 0 0 44 0 1 6 120
Dinamiche di mercato e intensità della concorrenza di prezzo nel segmento dei farmaci off patent. La posizione dell'Italia nel contesto europeo 0 1 2 47 0 2 8 159
Dynamic Competition in Pharmaceuticals: Patent Expiry, Generic Penetration, and Industry Structure 0 0 3 135 0 3 12 467
Federalismo e riparto del Fsn-2011: Much Ado About Nothing? 0 1 1 13 0 2 10 152
Generici vs. Branded: confronto internazionale su prodotti off-patent rimborsati dal SSN 0 0 0 12 0 0 5 78
Gli andamenti della spesa sanitaria: l'Italia in una sintetica comparazione internazionale 0 0 1 16 0 2 9 60
Global Competitiveness in Pharmaceuticals: A European Perspective 0 0 2 107 1 3 7 342
I Farmaci Oncologici in Italia: innovazione e sostenibilità economica 1 1 3 43 1 1 11 177
I farmaci ospedalieri tra Europa, Stato, Regioni e Cittadini 0 0 2 16 0 2 12 74
I numeri del Federalismo in Sanità - Benchmark e Standard per la Sanità Italiana, in attesa della decretazione attuativa della Legge n. 42-2009 0 1 1 16 2 4 11 75
I numeri del Federalismo in Sanità - Benchmarking e Standard su profili di spesa sanitaria per età 0 1 1 28 0 2 7 96
I numeri del federalismo: una simulazione per la sanità 0 1 1 9 0 2 10 62
I trend della spesa sanitaria e le ragioni del finanziamento multipillar con componente ad accumulazione reale 0 0 1 11 0 2 8 85
Il Decreto DL 15/04/2002, n. 63 sul Contenimento della Spesa Farmaceutica - Impatto sull'Industria e Distorsioni nel Funzionamento del Mercato 0 2 2 14 0 4 14 96
Il disegno delle nuove agevolazioni fiscali alla previdenza complementare - una quantificazione per un lavoratore dipendente neoassunto del settore privato 0 0 0 6 0 1 4 40
Il prezzo di riferimento nel quadro regolatorio del mercato farmaceutico 0 0 0 15 0 3 10 89
In attesa del federalismo compiuto: LEA, spesa sanitaria e risorse finanziarie a livello regionale 0 1 2 14 0 2 9 76
Inflazione, bassa crescita, Euro forte: tra problemi europei ed economia globale 0 1 1 7 0 2 3 56
Innovation and Corporate Dynamics: A Theoretical Framework 0 0 0 66 0 1 3 114
Innovation and Corporate Dynamics: A Theoretical Framework 1 1 4 146 3 6 13 238
Innovation and Corporate Growth in the Evolution of the Drug Industry 0 0 1 418 1 4 17 887
Introduzione. Liberalizzazioni e concorrenza in Italia 0 0 0 24 0 2 5 121
L'integrazione pubblico-privato in sanità e assistenza alla persona 0 0 2 13 0 2 11 66
La Riforma del Welfare, il Paygo, i nuovi Ammortizzatori per il Mercato del Lavoro 0 0 0 12 0 2 3 62
La Sostenibilità dei Sistemi Sanitari Regionali 0 0 2 22 0 1 12 91
La Sostenibilità dei Sistemi Sanitari Regionali 0 0 1 31 0 2 7 112
La distribuzione al dettaglio dei farmaci - tra regolazione efficiente e mercato 0 2 3 23 0 5 14 237
La nuova fiscalità della previdenza complementare per il lavoratore, l'impresa e l'Erario - Una quantificazione per il lavoratore dipendente neoassunto del settore privato con turnover decennale di datore di lavoro 0 1 1 11 0 2 4 55
La regolamentazione delle farmacie in Italia 0 0 2 23 1 2 10 96
La sanità in Italia - tra federalismo, regolazione dei mercati e sostenibilità delle finanze pubbliche 0 1 3 10 0 2 13 70
La spesa farmaceutica pubblica - Analisi degli ultimi anni e indicazioni per una nuova politica economica 0 1 2 16 0 2 8 62
La spesa farmaceutica territoriale convenzionata: il modello FarmaRegio per l'analisi della variabilità regionale 0 0 2 10 0 3 15 77
La spesa sanitaria delle Regioni in Italia - Saniregio 2015 0 1 5 63 0 9 33 205
La spesa sanitaria delle Regioni in Italia - Saniregio 3 0 0 0 45 0 3 11 175
La spesa sanitaria delle Regioni in Italia - Saniregio2017 0 2 6 36 1 6 29 116
La spesa sanitaria pubblica in Italia: dentro la "scatola nera" delle differenze regionali - Il modello SaniRegio 0 1 11 78 2 5 32 240
Le differenze regionali nella governance della spesa sanitaria - SaniRegio-2011 1 1 4 45 1 1 17 157
Le differenze regionali nella governance della spesa sanitaria. La sanità alla sfide del federalismo: il modello SaniRegio di CeRM 0 0 0 12 0 2 9 78
Le proiezioni della spesa sanitaria Ssn - SaniMod 2011-2030 0 0 2 48 0 2 13 160
Le proiezioni di lungo periodo della spesa sociale nell'UE: l'impatto demografico e il possibile impatto della tecnologia sulla spesa sanitaria 0 0 3 9 0 2 13 72
Market Structure and Drug Innovation 0 0 0 29 0 0 6 120
Medical Devices Competitiveness and Impact on Public Health Expenditure 2 3 8 163 3 8 30 611
Medical Devices: Competitiveness and Impact on Public Health Expenditure 0 0 1 23 1 3 11 111
Mezzogiorno d'Italia - Primo Baedeker dello sviluppo territoriale e regionale 0 1 2 6 0 1 9 57
Networks Dynamics in the Pharmaceutical Industry 0 0 0 1 0 0 0 249
Networks of innovators within and across borders. Evidence from patent data 0 0 1 107 1 3 8 211
Nuove politiche per l'innovazione nel settore delle scienze della vita 0 0 0 6 0 1 8 70
Occupazione, produttività e demografia: le sfide per la crescita del Mezzogiorno - Riforme strutturali per dare basi al federalismo 0 1 1 6 1 2 3 53
On Firm Growth in Networks 0 0 1 19 0 0 1 104
On Size and Growth of Business Firms 0 0 0 32 0 3 6 316
Opting-out previdenziale, smobilizzo del TFR e basi strutturali del pilastro privato 0 0 0 7 0 0 3 47
Patent Disclosure and R&D Competition in Pharmaceuticals 1 1 1 117 1 3 3 295
Patent Disclosure and R&D Competition in Pharmaceuticals 0 1 1 105 0 3 3 164
Patent Value and R&D Competition 0 0 0 1 0 0 0 24
Peer-Group Detection of Banks and Resilience to Distress 0 0 0 12 2 2 7 42
Preferential attachment and growth dynamics in complex systems 0 0 0 17 0 0 2 98
Processes of corporate growth in the evolution of an innovation-driven industry. The case of pharmaceuticals 0 1 4 247 0 1 6 506
R&D, Within and Between Patent Competition in the Pharmaceutical Industry 1 1 2 161 1 2 6 339
Regolazione, innovazione e ciclo di vita dei prodotti - per una riforma del pricing al lancio e della governance della spesa nella farmaceutica pubblica 0 0 0 12 1 4 13 77
Regole pensionistiche e incentivi al prolungamento della vita lavorativa: analisi del caso italiano 1 1 3 16 1 2 5 62
Regole pensionistiche e prolungamento dell'attività: analisi del TIR e effetti del cumulo lavoro-pensione 0 0 0 8 1 2 6 62
Spesa sanitaria, demografia, governance istituzionale - Tra trend storici e proiezioni a lungo termine 0 0 2 8 0 0 8 58
Statistical Properties of Business Firms Structure and Growth 0 0 1 16 0 0 4 76
Structure of Business Firm Networks and Scale-Free Models 0 0 0 52 0 1 1 230
Structure of Business Firm Networks and Scale-Free Models 0 0 0 11 0 0 0 85
Strumenti di regolazione del mercato farmaceutico: un'analisi ragionata 0 1 2 28 0 1 6 105
Systemic importance of financial institutions: from a global to a local perspective? A network theory approach 0 0 1 90 0 0 5 107
Systemic importance of financial institutions: regulations, research, open issues, proposals 0 2 3 46 0 6 12 178
Systemic risk and banking regulation: some facts on the new regulatory framework 0 0 3 132 0 4 8 198
Technological Regimes and the Growth of Networks An Empirical Analysis 0 0 0 129 1 2 6 340
The Accounting Network: how financial institutions react to systemic crisis 0 0 0 26 0 0 1 19
The Growth of Business Firms: Theoretical Framework and Empirical Evidence 1 1 6 150 13 38 210 1,284
The Growth of Business Firms: Theoretical Framework and Empirical Evidence 0 0 0 16 0 1 1 96
The Multipillar System for Health Care Financing: Thirteen Good Reasons for Open Capitalisation Funds, Covering both Pension and Health Care Provisions 0 0 0 30 0 2 4 72
The Nature and the Extent of the Market for Technology in Biopharmaceuticals 0 0 0 44 0 0 5 163
The Size Variance Relationship of Business Firm Growth Rates 0 0 0 27 1 1 2 73
The Size Variance Relationship of Business Firm Growth Rates 0 0 0 37 0 0 0 92
The Size Variance Relationship of Business Firm Growth Rates 0 0 0 30 0 0 0 77
The Sustainability of European Health Care Systems: Beyond Income and Ageing 0 0 1 1 0 1 8 25
The Sustainability of European Health Care Systems: Beyond Income and Ageing 0 2 3 56 0 3 8 185
The Value of Failures in Pharmaceutical R&D 0 0 0 30 0 0 4 112
The evolution of networks of innovators within and across borders: Evidence from patent data 0 0 3 137 0 1 7 161
The potential costs of Longevity Risk on Public Pensions. Evidence from Italian data 0 0 1 34 0 1 7 37
The productivity crisis in pharmaceutical R&D 0 0 6 161 0 2 19 435
Who is this, who enters there? - Migration in Italy and its effect on fiscal sustainability and pensions 0 0 1 97 2 5 19 185
Total Working Papers 9 38 145 4,784 45 235 989 16,527


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Breath of Fresh Air? Firm Type, Scale, Scope, and Selection Effects in Drug Development 0 1 2 29 0 3 11 107
A Comparison of U.S. and European University-Industry Relations in the Life Sciences 0 0 0 9 0 0 2 73
A generalized preferential attachment model for business firms growth rates 0 0 0 6 0 0 0 24
A generalized preferential attachment model for business firms growth rates 0 0 0 6 0 0 0 16
Assessing financial distress dependencies in OTC markets: a new approach using trade repositories data 0 0 2 8 0 0 10 40
Dynamic competition in pharmaceuticals 0 0 0 10 0 0 0 32
Economic evaluation of HIV treatments: The I.CO.N.A. cohort study 0 0 0 20 0 0 1 97
Innovation and corporate growth in the evolution of the drug industry 2 3 6 128 3 7 27 440
Intellectual property, technological regimes and market dynamics 0 0 2 11 1 1 8 35
La distribuzione dei farmaci tra progetti di riforma e incertezze 0 0 0 16 1 2 10 157
Learning from successes and failures in pharmaceutical R&D 0 1 5 11 0 4 16 53
On Innovation, Instability, and Growth. A Review and an Interpretative Framework 0 0 0 7 1 3 5 24
On firm growth in networks 0 0 0 66 0 0 7 168
On size and growth of business firms 0 0 0 5 0 2 4 19
On the size distribution of business firms 0 0 2 75 1 2 5 226
Patent disclosure and R&D competition in pharmaceuticals 0 0 0 61 0 1 2 285
Technological Regimes and the Growth of Networks: An Empirical Analysis 0 0 0 30 0 1 5 115
Technological change and network dynamics: Lessons from the pharmaceutical industry 0 0 5 173 0 0 9 451
The Evolution of Knowledge and the Dynamics of an Industry Network 0 1 1 77 0 2 4 293
The Growth of Business Firms: Facts and Theory 1 1 2 108 1 1 4 625
The changing boundaries of system companies 0 0 0 3 0 0 1 23
The evolution of networks of innovators within and across borders: Evidence from patent data 0 0 1 13 0 1 4 46
The intensity of competition after patent expiry in pharmaceuticals. A cross-country analysis 1 1 1 41 1 1 3 117
The price of pharmaceutical products in Italy. On some recent trends 0 0 0 10 0 1 1 27
The sustainability of European health care systems: beyond income and aging 0 0 1 23 0 1 6 83
Total Journal Articles 4 8 30 946 9 33 145 3,576


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Public Research and Industrial Innovation: A Comparison of US and European Innovation Systems in the Life Sciences 0 2 4 7 0 2 7 18
Technological Paradigms and the Evolution of Networks: Lessons from the Pharmaceutical Industry 0 0 0 6 1 1 2 14
Total Chapters 0 2 4 13 1 3 9 32


Statistics updated 2019-07-03